Australia’s Bionomics Unveils Therapeutic Action Of BNC210
This article was originally published in PharmAsia News
Executive Summary
Australia’s Bionomics unveils the therapeutic action of its BNC210 compound and faced shareholder questions all in one busy week for the biotech.